Načítá se...
COVID-19 in Immunocompromised Hosts: What We Know So Far
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and mortality for patients and stressed healthcare systems worldwide. The clinical features and outcomes of COVID-19 among immunosuppressed patient...
Uloženo v:
| Vydáno v: | Clin Infect Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337668/ https://ncbi.nlm.nih.gov/pubmed/33501974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa863 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|